BEAT: HeartBeam, Inc. PEG Multiple

HeartBeam, Inc. (BEAT) is a recognized innovator in remote cardiac monitoring, whose resilience to macroeconomic crises is based on constant demand within the medical sector. The stock's valuation based on the P/E ratio and growth demonstrates price dynamics where the 0.00 metric confirms the current level. The company is displacing cumbersome equipment by leveraging unique patents for real-time cloud-based ECG analysis.
Analytical breakdowns for HeartBeam, Inc. (BEAT)

The PEG ratio assesses the fairness of an asset's market value relative to its earnings growth rate. By analyzing the current P/E to growth dynamics, an investor determines the degree of business undervaluation when the value is below one. The metric is calculated by dividing the P/E ratio by the expected annual earnings growth percentage. For HeartBeam, Inc. (BEAT), the indicator is speculative in nature, as the lack of revenue from AI systems makes the calculation dependent on external financing.